Risk Assessment Helpful

Risk Assessment recommended

Patients with endometrial or colorectal cancer diagnosed before 50 years.

Patient with endometrial or ovarian cancer with synchronous or metachronous Lynch-associated malignancies.

Patients with colorectal or endometrial cancer and more than 2 first/second-degree relative meeting the above criteria.

Patient meeting revised Amsterdam criteria.*

Patient with synchronous oi metachronous colorectal and ovarian or endometrial cancers.

Patient with a first/second-degree relative with a known MMR mutation.

Patient with one of the above criteria have a 5-10% chance of Lynch Syndrome.

Patient with one of the above criteria have a 20-25% chance of Lynch Syndrome.